D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$773M |
| 2 |
Visa
V
|
+$674M |
| 3 |
HES
Hess
HES
|
+$541M |
| 4 |
Mastercard
MA
|
+$448M |
| 5 |
Oracle
ORCL
|
+$419M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$1.29B |
| 2 |
Advanced Micro Devices
AMD
|
+$979M |
| 3 |
Citigroup
C
|
+$477M |
| 4 |
Exxon Mobil
XOM
|
+$434M |
| 5 |
Booking.com
BKNG
|
+$355M |
Sector Composition
| 1 | Technology | 27.95% |
| 2 | Consumer Discretionary | 14.18% |
| 3 | Financials | 9.99% |
| 4 | Healthcare | 9.55% |
| 5 | Communication Services | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
876
Edgewise Therapeutics
EWTX
$1.55B
| $8.64M | 0.01% |
473,680
+441,730
| +1,383% | +$8.06M |
|
877
Equinox Gold
EQX
$8.58B
| $8.63M | 0.01% |
1,432,403
+301,589
| +27% | +$1.82M |
|
878
The Ensign Group
ENSG
$9.75B
| $8.61M | 0.01% |
69,187
+25,337
| +58% | +$3.15M |
|
879
Plains GP Holdings
PAGP
$3.69B
| $8.56M | 0.01% |
469,237
+83,079
| +22% | +$1.52M |
|
880
Xenon Pharmaceuticals
XENE
$2.87B
| $8.55M | 0.01% |
198,526
+114,373
| +136% | +$4.92M |
|
881
Knowles
KN
$1.91B
| $8.54M | 0.01% |
530,353
-93,517
| -15% | -$1.51M |
|
882
Nice
NICE
$8.81B
| $8.54M | 0.01% |
+32,760
| New | +$8.54M |
|
883
NCR Voyix
VYX
$1.8B
| $8.53M | 0.01% |
675,440
+485,358
| +255% | +$6.13M |
|
884
Western Alliance Bancorporation
WAL
$9.89B
| $8.52M | 0.01% |
132,783
-304,513
| -70% | -$19.5M |
|
885
AGNC Investment
AGNC
$10.8B
| $8.48M | 0.01% |
857,038
+815,761
| +1,976% | +$8.08M |
|
|
CHUY
886
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $8.47M | 0.01% |
251,077
+36,615
| +17% | +$1.24M |
|
887
Woodward
WWD
$14.4B
| $8.46M | 0.01% |
54,905
-16,620
| -23% | -$2.56M |
|
888
Rexford Industrial Realty
REXR
$10.3B
| $8.44M | 0.01% |
+167,879
| New | +$8.44M |
|
889
Assured Guaranty
AGO
$3.96B
| $8.42M | 0.01% |
96,507
-23,292
| -19% | -$2.03M |
|
890
Kimco Realty
KIM
$15.2B
| $8.42M | 0.01% |
429,342
+155,238
| +57% | +$3.04M |
|
891
Exact Sciences
EXAS
$10.6B
| $8.42M | 0.01% |
121,874
+99,127
| +436% | +$6.85M |
|
892
John Wiley & Sons Class A
WLY
$2.24B
| $8.41M | 0.01% |
220,444
| – | – |
|
893
Crown Holdings
CCK
$11.4B
| $8.4M | 0.01% |
+105,993
| New | +$8.4M |
|
894
Usana Health Sciences
USNA
$564M
| $8.4M | 0.01% |
173,209
+6,206
| +4% | +$301K |
|
895
Badger Meter
BMI
$5.34B
| $8.38M | 0.01% |
51,785
+479
| +0.9% | +$77.5K |
|
896
Coterra Energy
CTRA
$18.6B
| $8.38M | 0.01% |
300,507
-1,023,410
| -77% | -$28.5M |
|
897
Gates Industrial
GTES
$6.71B
| $8.33M | 0.01% |
470,191
+104,117
| +28% | +$1.84M |
|
|
WBA
898
DELISTED
Walgreens Boots Alliance
WBA
| $8.32M | 0.01% |
383,474
+328,703
| +600% | +$7.13M |
|
899
Kura Oncology
KURA
$766M
| $8.32M | 0.01% |
389,902
+184,282
| +90% | +$3.93M |
|
900
Cloudflare
NET
$78.3B
| $8.31M | 0.01% |
85,772
-90,878
| -51% | -$8.8M |
|